BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35625590)

  • 21. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
    Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
    BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are the somatic mutation and tissue organization field theories of carcinogenesis incompatible?
    Rosenfeld S
    Cancer Inform; 2013; 12():221-9. PubMed ID: 24324325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chaos and cancers. Theories concerning carcinogenesis.
    Kwasniewski W; Stupak A; Kotarski J; Gozdzicak-Jozefiak A
    Ginekol Pol; 2021; 92(4):318-321. PubMed ID: 33757157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical appraisal of the relative contribution of tissue architecture, genetics, epigenetics and cell metabolism to carcinogenesis.
    Grunt TW; Heller G
    Prog Biophys Mol Biol; 2023 Sep; 182():26-33. PubMed ID: 37268024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer epigenetics: Past, present and future.
    Lee JE; Kim MY
    Semin Cancer Biol; 2022 Aug; 83():4-14. PubMed ID: 33798724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The aging of the 2000 and 2011 Hallmarks of Cancer reviews: a critique.
    Sonnenschein C; Soto AM
    J Biosci; 2013 Sep; 38(3):651-63. PubMed ID: 23938395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.
    Xu W; Jiang T; Shen K; Zhao D; Zhang M; Zhu W; Liu Y; Xu C
    Front Endocrinol (Lausanne); 2023; 14():1224832. PubMed ID: 37608794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic mutation theory of carcinogenesis: why it should be dropped and replaced.
    Sonnenschein C; Soto AM
    Mol Carcinog; 2000 Dec; 29(4):205-11. PubMed ID: 11170258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergentism as a default: cancer as a problem of tissue organization.
    Soto AM; Sonnenschein C
    J Biosci; 2005 Feb; 30(1):103-18. PubMed ID: 15824446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of evolutionary processes in organismal and cancer evolution.
    Laukien FH
    Prog Biophys Mol Biol; 2021 Oct; 165():43-48. PubMed ID: 34509467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amazing roles of extrachromosomal DNA in cancer progression.
    Zhao L; Jiang Y; Lei X; Yang X
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188843. PubMed ID: 36464200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory.
    Soto AM; Sonnenschein C
    Bioessays; 2011 May; 33(5):332-40. PubMed ID: 21503935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aneuploidy, the somatic mutation that makes cancer a species of its own.
    Duesberg P; Rasnick D
    Cell Motil Cytoskeleton; 2000 Oct; 47(2):81-107. PubMed ID: 11013390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.
    Verhaak RGW; Bafna V; Mischel PS
    Nat Rev Cancer; 2019 May; 19(5):283-288. PubMed ID: 30872802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common cancers--genetics, origin, prevention, screening: Parts I and II.
    Schifeling DJ; Horton J; Tafelski TJ
    Dis Mon; 1997 Oct; 43(10):681-742. PubMed ID: 9374953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decoding the knots of initiation of oncogenic epithelial-mesenchymal transition in tumor progression.
    Guo P; Gao A; Zhang G; Han H; Zhou Q
    Curr Cancer Drug Targets; 2013 Nov; 13(9):996-1011. PubMed ID: 24168183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary predisposition to cancer.
    Knudson AG
    Ann N Y Acad Sci; 1997 Dec; 833():58-67. PubMed ID: 9616740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic somatic events in tissue-specific stem cells: a role in cancer recurrence?
    Hartwig FP; Nedel F; Collares T; Tarquinio SB; Nör JE; Demarco FF
    Ageing Res Rev; 2014 Jan; 13():100-6. PubMed ID: 24374269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular biology of colorectal cancer.
    Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
    Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.